XML 24 R15.htm IDEA: XBRL DOCUMENT v3.22.2
Earnings (Loss) Per Common Share
6 Months Ended
Jun. 30, 2022
Earnings (Loss) Per Common Share [Abstract]  
Earnings (Loss) Per Common Share
Note 8.
Earnings (Loss) Per Common Share



A reconciliation of the numerator and denominator used in the earnings (loss) per common share calculations is as follows:


   
Three Months Ended
June 30, 2022
 
   
Loss
   
Weighted
Average
Shares
(In thousands)
 
Per Share
Amount
 
Basic and Diluted Loss Per Common Share:
               
Net loss
  $ (1,679 )     20,402
     
Less preferred stock dividends
    (100 )    
       
   Net loss applicable to common shareholders
  $ (1,779 )     20,402
  $ (0.09 )


   
Three Months Ended
June 30, 2021
 
   
Income
   
Weighted
Average
Shares
(In thousands)
 
Per Share
Amount
 
Basic Earnings Per Common Share:
               
Net income
  $ 2,962       20,414
 
 
Less preferred stock dividends
    (100 )
   
 
 
   Net income applicable to common shareholders
    2,862
      20,414
  $ 0.14
 
Diluted Earnings Per Common Share:
                     
Effect of Series D preferred stock
    100
      1,378
       
Net income applicable to common shareholders
  $ 2,962       21,792
  $ 0.14
 

   
Six Months Ended
June 30, 2022
 
   
Income
   
Weighted
Average
Shares
(In thousands)
 
Per Share
Amount
 
Basic and Diluted Income Per Common Share:
               
Net income
  $ 1,163       20,391
   
 
Less preferred stock dividends
    (199 )    
       
Net income applicable to common shareholders
  $ 964       20,391
  $ 0.05  

   
Six Months Ended
June 30, 2021
 
   
Income
   
Weighted
Average
Shares
(In thousands)
   
Per Share
Amount
 
Basic and Diluted Income Per Common Share:
                 
Net income
  $ 2,531     20,415
     
 
Less preferred stock dividends
    (199 )    
         
Net income applicable to common shareholders
  $ 2,332     20,415
    $ 0.11


The assumed conversion of the Company’s Series D preferred stock was excluded from the earnings (loss) per common share calculation for all periods presented, except for the three month period ended June 30, 2021, since its impact would have been antidilutive.